Retina International is delighted to announce the appointment of Sarah McLoughlin as Science Communication Officer.
Sarah will be working on the implementation of RI’s communications strategy where she will play a key role in one of the organisations primary objectives: delivery of the latest information on relevant developments in research and innovation to members and stakeholders.
Sarah comes to Retina Inernational with a background in research and an interest in patient advocacy. She conducted a basic research PhD on retinal degeneration and circadian rhythms in Dr. Breandan Kennedy’s laboratory at University College Dublin (UCD). She continued her postdoctoral academic research in the laboratory of Dr. Garret FitzGerald at the University of Pennsylvania, USA, focusing on circadian rhythms and aging.
With the aim of learning about impactful patient advocacy, she completed the first Irish Patient Education Programme run by the Irish Platform for Patient Organisations Science and Industry (IPPOSI) in 2017/18. Sarah hopes to bring the skills gained through her science career, including biomedical research, teaching and science communication, to the patient-led retinal research space.
To contact Sarah email email@example.com